Drug General Information
Drug ID
D0O1PU
Former ID
DIB002232
Drug Name
BAY-39-9624
Indication Osteoporosis [ICD9: 733.0, V07.4; ICD10:M80-M81, Z79.890] Terminated [547256]
Company
Bayer AG
Target and Pathway
Target(s) Progesterone receptor Target Info Agonist [551732]
KEGG Pathway Oocyte meiosis
Progesterone-mediated oocyte maturation
Pathway Interaction Database Cellular roles of Anthrax toxin
Reactome Nuclear signaling by ERBB4
Nuclear Receptor transcription pathway
WikiPathways Ovarian Infertility Genes
Signaling by ERBB4
Nuclear Receptors
References
Ref 547256Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014491)
Ref 551732Bayer is seeking an exclusive licensee for its end-of-Phase I progestinagonist Bay 39-9624. Thepharmaletter. 29-04-2002.

If you find any error in data or bug in web service, please kindly report it to Dr. Wang and Dr. Li.